Rivastigmine Toxicity
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Double-Blind, Placebo-controlled Crossover Study of Repeat Rivastigmine Administration in Healthy Male Volunteers (NCT00624663) | Tel-Aviv Sourasky Medical Center | 2009-01-01 |
Track Rivastigmine Toxicity automatically
Every clearance here is in the API, with alerts when new ones post.